View More Recent Stories
-
ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets
-
ADIA Nutrition files provisional patent for regenerative medical protocol
-
Adia Med Files Provisional Patent for Breakthrough Regenerative Medical Protocol
-
Game-Changing Alliance: Adia Labs and Axia
-
Adia Nutrition Inc. Announces Transformative 2025 Milestones and Strategic Progress Toward Nasdaq Uplisting
-
Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth
-
Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med's Specialized Treatment Revolution
-
Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission
-
Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20%
-
ADIA divests Biolete coffee unit to Cement Factory, keeps 18% stake
-
Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales
-
Adia Nutrition Expands Rapidly, Tripling Sales Force with Regional Teams to Fuel U.S. and Worldwide Growth
-
Adia Nutrition Inc. Identifies Over 20 Million Potentially Improperly Issued Shares and Initiates Process to Return Shares to Treasury
-
Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue
-
Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market
-
Adia Med Surges Ahead of Growth Timeline With Venture Medical Partnership in $25B Wound Care Market
-
Adia Nutrition Launches Second National Television Campaign Showcasing U.S.-Based Regenerative Stem Cell Therapies
-
Adia Med Expands Into Wound Care, Targeting High-Demand $25 Billion Market and Unlocking New Growth Avenues
-
Adia Nutrition Inc. Celebrates Adia Med's Approval as a UnitedHealthcare Provider in $5.3 Trillion Healthcare Market
-
Adia Med adds glutathione therapies to regenerative medicine offerings
-
Adia Med Enters $1.9 Billion Glutathione Industry with Innovative IV and Transdermal Therapies, Expanding High-Demand Offerings
-
Adia Nutrition Inc. Celebrates Approval as Aetna Health Insurance Provider and Anticipates United Healthcare Approval for Adia Med Subsidiary
-
Adia Nutrition Inc. Supports Heroes and Their Families with TRICARE In-Network Application, Advancing Regenerative Care Through Adia Med
-
Adia Nutrition Partners with CareCredit to Offer up to $25,000 in Affordable Financing for Patient Treatments
-
Adia Nutrition Inc. Celebrates Grand Opening of Adia Med of San Antonio, First Licensed Clinic, Led by Michele DeLeon MD
-
Adia Nutrition Inc. Advances Toward United Healthcare Provider Approval for Adia Med Services, Signaling Major Growth Opportunity
-
Adia Nutrition Inc. Unveils Game-Changing Nationwide TV Commercial for Adia Vita: A New Era in Regenerative Medicine
-
Timing Is Everything - Adia Nutrition Inc. Celebrates Florida's SB 1768 with Open Invitations to Adia Med Clinic
-
Home Run! Adia Med of Winter Park's AHCA Triumph Brings Insurance-Covered Healing to Patients
-
Adia Nutrition Inc. Introduces Cherry Payment Plans at Adia Med Clinics, Enhancing Access to Innovative Therapies
-
Adia Nutrition Inc. Expands Business Model with Licensing Agreements to Meet Global Demand for Adia Med's Regenerative Therapies
-
CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance
-
Adia Nutrition, Inc. (ADIA) looks to uplist to OTCQB in plans to list on Nasdaq small cap
